Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026Q00822
NAICS
621511 - Medical Laboratories
Classification Code
6505
Additional Details
Documents1
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), has issued a solicitation for Thyroseq V3 molecular testing services for fine needle aspiration biopsy samples of thyroid nodules. This procurement, identified by number 75N98026Q00822, seeks to secure specialized medical laboratory services to support NIH’s ongoing clinical and research activities in Bethesda, Maryland.
The primary purpose of this solicitation is to obtain advanced molecular diagnostic testing—specifically, the Thyroseq V3 assay—for thyroid nodule samples collected via fine needle aspiration. The intended outcome is to enhance the accuracy of thyroid cancer diagnosis and inform patient management decisions, leveraging state-of-the-art molecular techniques. The scope of work encompasses the receipt, processing, and analysis of biopsy samples, with the expectation that results will be delivered in a timely and reliable manner to NIH clinicians and researchers.
Key requirements include the ability to perform Thyroseq V3 molecular testing in accordance with established clinical laboratory standards. Offerors must be classified under NAICS code 621511 (Medical Laboratories), and should demonstrate expertise in molecular diagnostics, particularly as applied to thyroid pathology. The expected deliverables are comprehensive test results for each submitted sample, supporting NIH’s mission to advance health and medical knowledge.
The place of performance is Bethesda, Maryland, with all services to be provided within the United States. The contracting entity is the NIH OLAO, operating under the Department of Health and Human Services. The primary point of contact for this opportunity is James B. Law, who can be reached at [email protected] for further information or clarification.
This solicitation is active and open for responses until July 27, 2026, at 13:07. Interested contractors should review the attached combined synopsis for detailed requirements and submission instructions. The procurement is classified under Product Service Code 6505, which pertains to medical and laboratory supplies and services. No set-aside requirements or special considerations are specified in the provided notice.
Contractors with proven capabilities in medical laboratory testing, particularly molecular diagnostics for thyroid nodules, are encouraged to evaluate this opportunity. The contract will require consistent, high-quality service delivery throughout its lifecycle, supporting NIH’s clinical and research objectives in Bethesda.
For full details and access to the solicitation documents, visit the official SAM.gov opportunity page at https://sam.gov/opp/faa146133ece4614ab73b5f945530dca/view.